DAWN
Day One Biopharmaceuticals, Inc. · Healthcare
0.00
0.00%(+0.00)
Market OpenLast Updated: — ET
52W L: $0.0052W H: $0.00
DAWN (1h)
Day One Biopharmaceuticals, Inc. · Healthcare
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN - Get Free Report)'s share price reached a new 52-week high during trading on Tuesday. The company traded as high as $21.47 and last traded at $21.46, with a volume of 904610 shares traded. The stock had previously closed at $21.45. Analysts Set New Price Targets A number of
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Day One Biopharmaceuticals, Inc. (NasdaqGS: DAWN) to Servier. Under the terms of the proposed transaction, shareholders of Day One will receive $21.50 in cash for each share of Day One that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate,.
Pre-Market Stock Futures: Futures are trading lower as we hit the mid-point of the trading week, and while we didn't see the snapback rally that was the star of the show Monday, at least all four major indices held their own as the conflict in Iran grinds on. The Nasdaq was able to eke out... Here Are Wednesday's Top Wall Street Analyst Research Calls: CrowdStrike, Harley-Davidson, Intuitive Surgical, Medline, Nike, Oracle, Planet Fitness, Vici Properties, and More.
Day One Biopharmaceuticals (NASDAQ: DAWN) executives highlighted accelerating commercial momentum for OJEMDA and outlined multiple upcoming clinical catalysts during a fireside chat at TD Cowen's 46th Annual Healthcare Conference. Charles York, the company's CFO and COO, said 2025 marked a "fantastic year" for Day One as it delivered its first full year of OJEMDA sales following
Pre-Market Stock Futures: Futures are trading lower as many across Wall Street breathed a semi-sigh of relief yesterday after oil futures, which shot up to $120 overnight, retreated below $100 on Monday. That was the biggest spike in oil pricing since 2020. With the retreat in the black gold, the major indices did a massive... Here Are Tuesday's Top Wall Street Analyst Research Calls: AT&T, Amgen, CrowdStrike, Gilead, Hims and Hers, Intuit, Lowe's, Qualcomm, Rivian, Strategy and More.
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers.
Merendino Lauren
officer: Chief Commercial Officer
4,625 SH @ $0.00
2026-02-15
Merendino Lauren
officer: Chief Commercial Officer
4,625 SH @ $0.00
2026-02-15
Merendino Lauren
officer: Chief Commercial Officer
3,687 SH @ $0.00
2026-02-15
Merendino Lauren
officer: Chief Commercial Officer
5,814 SH @ $11.60
2026-02-17
Merendino Lauren
officer: Chief Commercial Officer
3,688 SH @ $0.00
2026-02-15
Merendino Lauren
officer: Chief Commercial Officer
3,162 SH @ $0.00
2026-02-15
Merendino Lauren
officer: Chief Commercial Officer
3,687 SH @ $0.00
2026-02-15
Merendino Lauren
officer: Chief Commercial Officer
3,688 SH @ $0.00
2026-02-15